The network of medical clinics InMedica has acquired the dental clinic operating in Klaipėda – Danta – which provides oral hygiene, dental filling, teeth removal, prosthetics, and implantation services. Danta is the first clinic providing dental services in Klaipėda purchased by the network.
“Danta is one of the longest-operating dental clinics on the market in Klaipėda with a wide circle of loyal customers. We value the work of the clinic as well as the accumulated years of experience and do no doubt that we will continue to successfully ensure the highest quality of services. After the acquisition, all the specialists, true experts in their respective fields, currently working at Danta plan to continue working at the clinic. Therefore, we will strive for this investment to become an even greater motivation for the team to work here,” says the CEO of InMedica, Kęstutis Broniukaitis.
InMedica has purchased 100 percent of Danta shares from the company’s director, Jelena Pocienė.
“Over the years, Danta has become a clinic for all family members, where innovative solutions are applied, and exceptional attention is paid to the highest quality of services. We believe that the partnership with InMedica will allow the clinic team to use its existing competencies even more efficiently and create even greater value for our patients”, says the director of the clinic Jelena Pocienė.
Clinic Danta was founded in 2004. Currently, the clinic has 5 thousand registered patients. The company employs 7 dental specialists. This year, the clinic plans to earn € 750 thousand in turnover.
About InMedica
After merging with MediCA Group, InMedica is the largest private healthcare service provider in Lithuania with a network of 82 clinics. InMedica provides diagnostic, outpatient, surgery, dentistry and other medical services. InMedica group consists of 63 family medicine centres, 6 broad-profile hub clinics, 8 specialized clinics, 5 walk-in clinics and 3 laboratories.
InMedica group has more than 2900 employees, provides healthcare services to more than 270 thousand registered patients and generated revenues over EUR 84 million. 45% of the shares of InMedica are owned by INVL Baltic Sea Growth Fund, one of the largest private equity investment funds in the Baltic States, through its subsidiary BSGF Sanus, 40% is controlled by Repharm, the largest Latvian private medicine group while the remaining 15% are owned by Litgaja UAB.
About INVL Baltic Sea Growth Fund
INVL Baltic Sea Growth Fund with its total size of €165mn is the leading private equity fund in the Baltics with the European Investment Fund (“EIF”) acting as its anchor investor.
The EIF has committed €30mn with the support of the European Fund for Strategic Investments, a key element of the Investment Plan for Europe (or the ‘Junker Plan’), as well as allocating resources from the Baltic Innovation Fund, the “fund of funds” initiative developed in cooperation with the governments of Lithuania, Latvia and Estonia. This aims to increase capital investment in high growth potential small and medium-sized enterprises in the Baltic States.
The Fund seeks to assemble a diversified portfolio of companies, targeting majority or significant minority stake deals and writing tickets of €10mn to €30mn, that showcase high growth potential and the ability to compete on a truly global basis.
The Fund is focused on the Baltic States and the neighbouring regions of Poland, Scandinavia and Central Europe specifically. The Fund so far has invested in six companies within the healthcare, civil engineering, environmental management (plastic recycling and waste management), veterinary services and cosmetics and hygiene products manufacturing sectors.
The Fund is managed by the leading in the Baltic region investment management and life insurance group INVL. The Group’s companies manage pension, mutual funds and life insurance commitments as well as individual portfolios, private equity and other alternative investment products. More than 290,000 clients across Lithuania, Latvia and Estonia plus international investors have entrusted the Group’s companies with the management of over EUR 1.7 billion in assets. The Group has a strong track record managing private equity assets and building leading market players in the Baltic countries and the Central and Eastern European region for over 30 years.